These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8529722)

  • 1. Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
    Eur Neurol; 1995; 35 Suppl 1():1-46. PubMed ID: 8529722
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
    Sebban C
    Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728
    [No Abstract]   [Full Text] [Related]  

  • 4. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
    Poitrenaud J; Laurent B; Sebban C
    Eur Neurol; 1995; 35 Suppl 1():43-6. PubMed ID: 8529729
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
    Bentué-Ferrer D; Decombe R; Reymann JM; Schatz C; Allain H
    Clin Neuropharmacol; 1990; 13 Suppl 3():S9-25. PubMed ID: 2093421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of almitrine/raubasine on cerebral metabolism in the elderly].
    Allain H; Bentué-Ferrer D
    Presse Med; 2002 Mar; 31(12):562-4. PubMed ID: 11984975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
    Pujol JF; Ginovart N; Debure L; Rousset C; Weissmann D
    Eur Neurol; 1995; 35 Suppl 1():12-6. PubMed ID: 8529723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental models in cerebral ischemia: application to the study of duxil].
    Labrid C
    Rev Med Interne; 1988 Feb; 9(1):21-6. PubMed ID: 3291037
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
    Depresseux JC; Franck G; Van Cauwenberge H; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S40-9. PubMed ID: 2093417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
    Mémin Y
    Rev Med Interne; 1988 Feb; 9(1):64-72. PubMed ID: 3387704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
    Guez D
    Rev Med Interne; 1988 Feb; 9(1):33-9. PubMed ID: 3260395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of 5023 SE on experimental cerebral ischemia in gerbils].
    Duhault J; Roman F; Dellazuana O; Actis H
    Presse Med; 1983 Mar; 12(13):844-6. PubMed ID: 6220333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
    Chan P; Li Y; Zheng Z; Hu P; Sarbach SD; Guez D
    Eur J Pharmacol; 1993 Feb; 231(2):175-82. PubMed ID: 8453973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
    Depresseux JC; Franck G; Van Cauwenberge H
    Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almitrine-Raubasine combination for dementia.
    Yang W; Liu M; Teng J; Hao Z; Wu B; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008068. PubMed ID: 21412915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.